BIAB
LIVE

Serial Number

79414867

Owner

Centillion Technology Limited

Attorney

Peter Kunin

Filing Date

May 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIAB Trademark

Serial Number: 79414867 • Registration: 8064109

BIAB is a trademark filed by Centillion Technology Limited on May 29, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Centillion Technology Limited (5 trademarks)

Harwood House, 43 Harwood Road

Entity Type: 98

Trademark Details

Filing Date

May 29, 2024

Registration Date

December 16, 2025

Published for Opposition

October 28, 2025

Goods & Services

Chemicals used in industry and science; catalysts for chemical and biochemical processes; biochemical catalysts; synthetic catalysts for chemical and biochemical processes; catalyst supports, namely, catalyst carriers; supports for catalysts; nucleic acids other than for medical or veterinary purposes, namely, nucleic recombinant acids; nucleic acids for scientific purposes; nucleic acids other than for medical or veterinary purposes, namely, nucleic acid for use in nucleic acid amplification processes; nucleic acid sequencing programs other than for medical or veterinary purposes; chromatography chemicals, namely, chromatographic material for the treatment of nucleic acids for scientific laboratory use; nucleic acid reagents other than for medical or veterinary purposes, namely, nucleic acid reagents for use in forensic analysis; chemicals for use in multiplying nucleic acid amounts other than for medical and veterinary use; chemicals for use in performing nucleic acid polymerase chain reactions other than for medical and veterinary use; stem cells for research or scientific purposes; chemical additives for use in fermentation; enzymes for use in the field of scientific and medical research, namely, enzymes for use in fermentation; proteins in raw material form for use in the field of scientific and medical research, namely, proteins for use in fermentation; ribonucleic acids other than for medical or veterinary purposes, namely, synthetic ribonucleic acid; synthetic messenger ribonucleic acid, other than for medical use; cell cultures, other than for medical use, namely, cell cultures for scientific purposes; proteins in raw material form for use in the field of scientific and medical research, namely, proteins for use in cell expansion and synthesis, other than for medical use; reagents for use in scientific research; monoclonal antibodies for scientific or research use; ferments for chemical purposes, namely, milk ferments for industrial chemical purposes; enzymes for scientific purposes

Pharmaceutical preparations, namely, RNA-based vaccines, RNA-based therapies for the treatment of cancers and auto-immune diseases, and protein replacement therapies for the treatment of cancers and auto-immune diseases; medical preparations, namely, diagnostic preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; nucleic acid for use in nucleic acid amplification processes for medical use; nucleic acid sequencing programs for medical use; chemical reagents for medical use, namely, chemicals for use in multiplying nucleic acid amounts for medical use; chemical reagents for medical use, namely, chemicals for use in performing nucleic acid polymerase chain reactions for medical use; pharmaceutical preparations being RNA-based therapies and vaccines, namely, pharmaceutical preparations containing stem cells for the treatment of cancers and autoimmune diseases; stem cells for medical purposes; surgical implants comprised of living tissues, namely, surgical implants grown from stem cells; synthetic ribonucleic acid for medical use; synthetic messenger ribonucleic acid for medical use; cell cultures for medical use; protein arrays for use in cell expansion and synthesis for medical use; vaccines; vaccines for human use; biologics for human use, namely, biological reagents for medical use; hormones for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; immunostimulants; antibodies for medical purposes; reagents for medical purposes; antibiotics; therapeutic protein arrays for medical purposes for RNA-based therapies and vaccines; ferments for pharmaceutical purposes; enzymes for medical purposes

Scientific and technological services, namely, scientific research, analysis, and testing in the fields of flow chemistry, and research and design relating thereto; industrial analysis services, namely, chemical analysis; industrial research services in the field of chemistry; design and development of computer hardware and software; computer programming; installation, maintenance and repair of computer software; computer consultancy services, namely, computer software consultancy; chemical design services, namely, custom design and development of chemical reagents and biochemical assays; design for others in the field of chemistry, namely, services for the design of theoretical chemical structures; design for others in the field of chemistry, namely, services for the design of substances which possess specific properties; biotechnology research; biotechnology research, namely, biotechnology testing; gene therapy research; vaccine research and development services; research and development of medicines; research and development of pharmaceuticals; research and development of medicines being biologics; scientific research and development, namely, research and development in relation to biomanufacturing; information, advice and consultancy in relation to the aforesaid services

Chemical processing machines for use in synthesis, modification, catalysis, analysis, transport or storage of chemicals, nucleic acids, chemical mixes, reagents or reactants; filtration machines, namely, machines used for process filtration in the pharmaceutical industry; machine parts, namely, washers for apparatus and instruments for regulating or controlling chemical reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems; reactors being industrial chemical installations; industrial chemical reactors, namely, reactors for gas-gas reactions; industrial chemical reactors, namely, reactors for gas-solids reactions

Stem cell therapy services; information, advice and consultancy in relation to the aforesaid services.

valves for controlling fluid levels in pharmaceutical and vaccine manufacturing systems; bioreactors for use in the treatment of waste, namely, biological reactors for clarifying industrial effluents; sterilisation equipment for use in laboratories, namely, chemical sterilization units; fluid separation apparatus, namely, extraction columns for use in the scientific research, medical research and pharmaceutical industries; apparatus and instruments for heating and cooling chemicals within pharmaceutical and vaccine manufacturing systems

Scientific apparatus and instruments for measuring DNA, RNA and protein; weighing apparatus and instruments; laboratory apparatus and instruments for measuring characteristics of RNA; scientific research and laboratory apparatus and equipment, namely, laboratory chemical reactors, flow reactors for laboratory use, baffled flow reactors for laboratory use; scientific apparatus and instruments for routing, regulating or controlling the flow of chemicals within pharmaceutical and vaccine manufacturing systems; scientific apparatus and instruments for regulating or controlling the reactions between chemicals within pharmaceutical and vaccine manufacturing systems; data processing equipment and computers; computer hardware; downloadable computer firmware for operating chemical reactors; downloadable computer software for operating chemical reactors; software downloadable from the Internet for operating chemical reactors; downloadable electronic publications in the nature of journals in the field of scientific and medical research; laboratory chemical reactors; scientific apparatus, namely, flow reactors and baffled flow reactors for laboratory use; modular chemical reactors for laboratory use; reconfigurable chemical reactors for laboratory use; bio photochemical reactors for laboratory use; photochemical reactors for laboratory use; nucleic acid sequencers for scientific purposes; laboratory apparatus for fermentation; scientific apparatus, namely, filtration membranes for laboratory apparatus for use in the science and research industry; feedback control systems comprised primarily of microprocessors, sensors, programmable logic controllers, graphics processing units, and microcontrollers for laboratory chemical reactors; downloadable industrial process control software; downloadable software for the design of theoretical chemical structures; downloadable genetic algorithm software, namely, downloadable computer software used to solve optimisation problems based on natural selection; reaction chambers for laboratory use; scientific apparatus, namely, baffles for routing, regulating or controlling the flow of chemicals or reagents within pharmaceutical and vaccine manufacturing systems; blades being parts of laboratory apparatus and instrument for regulating or controlling reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems; membranes for laboratory apparatus, namely, membranes for use as part of chemical reactors; parts for laboratory chemical reactors, namely, supports specifically adapted for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems; scientific mixing systems comprised primarily of a flow bioreactor, a fluid oscillator, fluidic pumps, fluidic valves, heat transfer systems, static fluid mixing systems, and microfluidic reactor chips used in connection with apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a flow bioreactor system; injection systems comprised primarily of fluid dispensing pumps, syringe pumps, peristaltic pumps, piston pumps, selector valves, and non-return valves used in connection with apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within pharmaceutical and vaccine manufacturing systems; custom components for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a system, namely, custom laboratory chemical reactors; coated components for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a system, namely, coated laboratory chemical reactors; printed components for apparatus and instruments for regulating or controlling reactions, biochemical processes or biological processes between chemicals within a system, namely, printed laboratory chemical reactors

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 16, 2026 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 5, 2026 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 16, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 24, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 24, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 24, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 24, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 12, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 25, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 24, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 16, 2025 REPR